Dunford EC, Herbst EA, Jeoung NH, Gittings W, Inglis JG, Vandenboom R, LeBlanc PJ, Harris RA, Peters SJ. PDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: effect of PDH kinase 1 compensation. Am J Physiol Regul Integr Comp Physiol 300: R1487-R1493, 2011. First published March 16, 2011 doi:10.1152/ajpregu.00498.2010.-Pyruvate dehydrogenase (PDH) plays an important role in regulating carbohydrate oxidation in skeletal muscle. PDH is deactivated by a set of PDH kinases (PDK1, PDK2, PDK3, PDK4), with PDK2 and PDK4 being the most predominant isoforms in skeletal muscle. Although PDK2 is the most abundant isoform, few studies have examined its physiological role. The role of PDK2 on PDH activation (PDHa) at rest and during muscle stimulation at 10 and 40 Hz (eliciting low-and moderate-intensity muscle contractions, respectively) in isolated extensor digitorum longus muscles was studied in PDK2 knockout (PDK2KO) and wild-type (WT) mice (n ϭ 5 per group). PDHa activity was unexpectedly 35 and 77% lower in PDK2KO than WT muscle (P ϭ 0.043), while total PDK activity was nearly fourfold lower in PDK2KO muscle (P ϭ 0.006). During 40-Hz contractions, initial force was lower in PDK2KO than WT muscle (P Ͻ 0.001) but fatigued similarly to ϳ75% of initial force by 3 min. There were no differences in initial force or rate of fatigue during 10-Hz contractions. PDK1 compensated for the lack of PDK2 and was 1.8-fold higher in PDK2KO than WT muscle (P ϭ 0.019). This likely contributed to ensuring that resting PDHa activity was similar between the groups and accounts for the lower PDH activation during muscle contraction, as PDK1 is a very potent inhibitor of the PDH complex. Increased PDK1 expression appears to be regulated by hypoxia inducible factor-1␣, which was 3.5-fold higher in PDK2KO muscle. It is clear that PDK2 activity is essential, even at rest, in regulation of carbohydrate oxidation and production of reducing equivalents for the electron transport chain. In addition, these results underscore the importance of the overall kinetics of the PDK isoform population, rather than total PDK activity, in determining transformation of the PDH complex and PDHa activity during muscle contraction. pyruvate dehydrogenase 4; pyruvate dehydrogenase 1; carbohydrate oxidation; hypoxia inducible factor-1␣; E1␣; E2 THE PYRUVATE DEHYDROGENASE (PDH) complex plays a major role in the regulation of glucose homeostasis by catalyzing the decarboxylation of pyruvate to acetyl-CoA. PDH links glycolysis to the tricarboxylic acid (TCA) cycle, as PDH controls carbohydrate oxidation by regulating the entrance of carbohydrate-derived acetyl units into the TCA cycle (10). PDH activation is regulated through reversible phosphorylation and dephosphorylation carried out by intrinsic regulatory enzymes. Sequential phosphorylation of E1 at three specific serine residues, serine 264 (site 1), serine 271 (site 2), and serine 203 (site 3), by a family of PDH kinases (PDK1, PDK2, PDK3, PDK4) renders the complex inactive (42, 43), while a pair of PDH phosphatases (PDP1 and PDP2) removes phosphates, thereby activating the PDH enzyme complex (15). The active state of PDH (PDHa), therefore, is ultimately determined by the relative activities of the PDKs and PDPs, which are separately regulated by differing concentrations of intramitochondrial effectors. Skeletal muscle PDP activity is most sensitive to activation through increased Ca 2ϩ concentrations; therefore, PDH activation generally increases with increasing intensity of contraction (14, 15) . PDK activity is positively affected by the products of the PDH reaction (NADH, high energy charge, and acetyl-CoA), causing lower PDH activity, while decreasing energy charge (increasing ADP) and increasing pyruvate concentrations inhibit PDK activity and increase PDHa activation (as reviewed in Refs. 10, 39).
THE PYRUVATE DEHYDROGENASE (PDH) complex plays a major role in the regulation of glucose homeostasis by catalyzing the decarboxylation of pyruvate to acetyl-CoA. PDH links glycolysis to the tricarboxylic acid (TCA) cycle, as PDH controls carbohydrate oxidation by regulating the entrance of carbohydrate-derived acetyl units into the TCA cycle (10) . PDH activation is regulated through reversible phosphorylation and dephosphorylation carried out by intrinsic regulatory enzymes. Sequential phosphorylation of E1 at three specific serine residues, serine 264 (site 1), serine 271 (site 2), and serine 203 (site 3), by a family of PDH kinases (PDK1, PDK2, PDK3, PDK4) renders the complex inactive (42, 43) , while a pair of PDH phosphatases (PDP1 and PDP2) removes phosphates, thereby activating the PDH enzyme complex (15) . The active state of PDH (PDHa), therefore, is ultimately determined by the relative activities of the PDKs and PDPs, which are separately regulated by differing concentrations of intramitochondrial effectors. Skeletal muscle PDP activity is most sensitive to activation through increased Ca 2ϩ concentrations; therefore, PDH activation generally increases with increasing intensity of contraction (14, 15) . PDK activity is positively affected by the products of the PDH reaction (NADH, high energy charge, and acetyl-CoA), causing lower PDH activity, while decreasing energy charge (increasing ADP) and increasing pyruvate concentrations inhibit PDK activity and increase PDHa activation (as reviewed in Refs. 10, 39) .
PDK1, PDK2, and PDK4 are the predominant isoforms in human and rodent skeletal muscle. PDK2 and PDK4 are the most studied isoforms in skeletal muscle, with PDK2 being the most abundantly expressed isoform in human and rodent skeletal muscle (3, 8) . Each PDK isoform has different specific activities and different sensitivities to pyruvate and ADP, which allows for individual responses to changing metabolic demands by targeting specific isoforms for upregulation (26, 39) .
In comparison to PDK2 and PDK4, PDK1 expression is low, but it is highly insensitive to pyruvate and ADP inhibition, and it has the highest specific activity. PDK1 is found in measurable quantities only in heart muscle (3) and oxidative skeletal muscle (32) , and no studies have demonstrated alterations to PDK1 protein expression in response to physiological perturbations such as starvation, high-fat diet, or exercise (32, 39) .
PDK4 expression is increased during acute changes in fat and carbohydrate availability (starvation, high-fat diet, diabetes), potentially due to its insensitivity to pyruvate inhibition, which is thought to preserve three-carbon intermediates in the face of carbohydrate deprivation (13) . In addition, PDK4 mRNA expression is increased during and following prolonged exercise (35) , and protein content is increased when muscle glycogen stores are depleted (22) . PDK4 has a higher specific activity than PDK2, but PDK2 is more sensitive to pyruvate and ADP inhibition (3, 39) . In contrast, PDK2 has been shown to respond to endurance exercise training and has been termed the "energy-sensitive" isoform (26) but, generally, remains unchanged after dietary challenges (starvation, high-fat diet) (13, 19, 32, 33) .
While PDK4 has been the focus of many studies (12, 13, 16, 18 -20, 22, 33) , little work has been done to examine the more dominant PDK2. In addition, because the kinases act to decrease oxidative carbohydrate disposal, PDK2 inhibition has been targeted as a therapy for type 2 diabetes (29, 30) , but complete loss of PDK2 function has not been investigated. Therefore, PDK2 knockout (PKD2KO) mice were used to examine the role of PDK2 in regulating PDHa activity at rest and during low-and moderate-intensity muscle contraction in vitro. Our hypothesis was that the absence of the most abundant isoform, PDK2, would result in a profound increase in PDHa activity in PDK2KO mice compared with wild-type (WT) mice at rest and during contraction. Because PDK2 represents the largest population of kinases in the mammalian complex, we also tested for the upregulation of alternate PDK isoforms (PDK1 and PDK4) as a compensatory strategy.
METHODS

Generation of the PDK2KO mice.
To construct the targeting vector, a PCR-amplified 2.0-kb DNA fragment located between exon 1 and exon 2 of the PDK2 gene was inserted into the SalI site of a pBluescript II/neo-TK vector (1) that contains the phosphoglycerate kinase promoter driving the neo gene (PGK-neo) and the herpes virus thymidine kinase (TK) gene. A 7.0-kb DNA fragment containing part of exon 2 and extending through exon 3 of the gene was inserted at the XhoI site. The vector was linearized at NotI and used for electroporation into R1 embryonic stem cells (129SvJ origin) by the Transgenic Facility of the Indiana University School of Medicine. The disrupted allele was confirmed by Southern blot analysis with a radiolabeled PCR-amplified DNA fragment from exon 8 to exon 10. Genotyping of mice was performed by PCR (40 cycles at 95°C for 30 s, 57°C for 30 s, and 65°C for 4 min). Primer 1 (5=-gactttcataacacccagtctcc-3=) and primer 2 (5=-cgcttttctggattcatcgactgtggc-3=) were used to amplify a 1.4-kbp fragment from the targeted allele. Primers 1 and 3 (5=-ggtgctcgagcctgggtgaagg-3=) produced a 1.2-kbp fragment from the WT allele. To stabilize the genetic background, heterozygous mice were backcrossed with C57BL/6J WT mice for six generations.
Experimental protocol. Female PDK2KO and WT C57BL/6J mice were obtained from colonies maintained by Dr. Robert Harris (Department of Biochemistry and Molecular Biology, Indiana University School of Medicine). The animals were housed in a controlled environment and fed Purina Rat Chow (Ralston Purina) ad libitum. The study was approved by the Brock University Animal Care and Utilization Committee and conformed to all guidelines of the Canadian Council for Animal Care (Animal Utilization Project Proposal 05-12-01).
Animals were anesthetized with pentobarbital sodium (6 mg/100 g body wt ip), and the extensor digitorum longus (EDL) and remaining mixed hindlimb muscles (gastrocnemius, plantaris, soleus) were removed. The hindlimb muscles were minced with scissors on ice, and the minced muscles were frozen immediately and kept for Western blot analysis of hypoxia inducible factor (HIF)-1, or the mitochondria were immediately extracted from fresh muscle and prepared for analysis of PDK activity and Western blotting of the PDK isoforms (32, 34) . Although two different muscles were used for analysis, both were predominantly type II fibers (ϳ92-96% type II in each) and differed slightly in terms of the proportion of oxidative to glycolytic fibers (ϳ58% compared with ϳ30% type IIa fibers for EDL and mixed hindlimb, respectively) (6, 9) . A suture was placed on both tendons of each EDL muscle, and the muscle was immediately placed in an organ bath filled with oxygenated (95% oxygen-5% carbon dioxide gas mixture) liquid medium 199 (catalog no. M4530, Sigma Aldrich, St. Louis, MO) and suspended at a resting tension of 1 g. Muscles were equilibrated by incubation at rest for 30 min, during which time optimum voltage and muscle length were determined. Optimal stimulus voltage and optimal length were determined by a force transducer (model FT03 with P11T amplifier, Grass Instruments, West Warwick, RI). To establish optimal stimulus voltage, the muscle was suspended at 1 g of resting tension and stimulated with a single twitch, starting at 10 V, and then with additional single twitches until a plateau in force production was observed (ϳ50 -70 V). After the initial equilibration, the muscles were removed and freezeclamped within 10 s (rest) or stimulated with tetanic contractions every 5 s for 3 min at 10 Hz (low-intensity contraction) or 40 Hz (moderate-intensity contraction); then they were removed and freezeclamped for further analysis. The stimulation protocol for each contraction intensity consisted of a 200-ms train duration and 0.2 train per second. Low and moderate stimulus rates were chosen to elicit a range of PDHa activities that would be up to ϳ50% of predicted maximal PDHa activity. For pilot experiments to establish a force-frequency curve, separate incubated muscles (n ϭ 5) from PDK2KO and WT mice were used. Muscles were stimulated from 1 to 40 Hz, and these frequencies were plotted against force production relative to maximal force, which was achieved at ϳ150 Hz. A frequency of 10 Hz was able to stimulate the muscle to ϳ20% of its maximal force and was therefore selected as the low-intensity frequency. However, a frequency of 40 Hz stimulated the muscle to contract at ϳ55% of its maximal force and therefore was selected as the moderate-intensity frequency (data not shown). All contraction data were recorded using a Polyview Data Acquisition and Analysis System (Grass Instruments) and analyzed using Polyview Reviewer (Grass Instruments).
PDK activity. Intact mitochondria were extracted from mixed mouse hindlimb muscle (17, 27) , with the final mitochondrial suspension resuspended in a sixfold carbonylcyanide m-chlorophenylhydrazone buffer and incubated for 20 min at 30°C. This procedure decreases ATP concentrations to zero, resulting in complete conversion of PDH to PDHa (34) . Mitochondria were pelleted at 7,000 g for 10 min and stored in liquid nitrogen for further analysis of PDK activity, as previously described (33, 34) .
Western blotting. For PDK isoform [PDK1 (48 kDa), PDK2 (46 kDa), and PDK4 (46 kDa)], PDH subunit [E1␣ (42 kDa) and E2 (52 kDa)], and cytochrome c oxidase (COX) IV (18 kDa) proteins, mitochondria were diluted to a final protein concentration of 1.0 g/l in 50 mM Tris·HCl, pH 6.8, containing 2% SDS, 0.1 M dithiothreitol, 0.1% bromphenol blue, 10% glycerol, and a protease inhibitor cocktail (1 mM benzamidine, 0.1 mg/ml trypsin inhibitor, 0.1 mM tosyllysyl-phenylmethylketone), as previously described (26, 33) . For HIF-1␣ (105 kDa), a 10-to 15-mg piece of muscle was chipped from frozen hindlimb and homogenized on ice in 100 volumes of homogenizing buffer (250 mM sucrose, 100 mM KCl, 2 mM EDTA, pH 6.8) also containing the protease inhibitor cocktail listed above. Homogenizations and blotting were repeated two to three times to ensure similar results from different pieces. Standard SDS-PAGE was performed using 12% separating gel, and for PDK isoforms, E1␣, E2, and COX IV, 10 g of mitochondrial protein were loaded per lane, while for HIF-1␣, 20 g of protein were added. The proteins were then transferred onto polyvinylidene difluoride (Millipore, Billerica, MA) using the tank method of electrophoretic transfer (Bio-Rad, Hercules, CA) with a transfer buffer containing 34.8 mM Tris base, 31.2 mM glycine, 0.03% (wt/vol) SDS, and 20% (vol/vol) absolute methanol (26) . Membranes were blocked in TBST buffer [20 mM Tris base, 137 mM NaCl, 0.1% (vol/vol) Tween 20, pH 7.5] and 5% dry milk overnight with 5% milk-TBST containing a 1:1,000 dilution of monoclonal antibodies against PDK1 (catalog no. AB 47987, Abcam, Cambridge, MA), PDK2 (catalog no. AP 7039b, Abgent, San Diego, CA), PDK4 (catalog no. AP 7041b, Abgent), COX IV (catalog no. MS 407, Mitosciences, Eugene, OR), E1␣ (catalog no. A 21323, Molecular Probes, Eugene, OR), and E2 (catalog no. A 21325, Molecular Probes). For HIF-1␣, membranes were blocked for 1 h and incubated overnight with 5% milk-TBST containing monoclonal antibodies against HIF-1␣ (1:500 dilution; catalog no. NB-100-449, lot A3, Novus Biologicals). Membranes were washed with TBST and incubated for 1 h in 5% milk-TBST containing secondary antibodies: for PDK2, PDK4, and HIF-1␣, a 1:20,000 dilution of goat anti-rabbit horseradish peroxidase (HRP)-conjugated IgG (Santa Cruz Biotechnology, Santa Cruz, CA); for PDK1, bovine anti-goat HRP-conjugated IgG (Santa Cruz Biotechnology); and for COX IV, E1␣, and E2, anti-mouse HRP (26) . Membranes were washed with TBST, visualized with the chemiluminescence substrate Chemiglow (Alpha Innotech, San Leandro, CA), and detected with Fluro Chem 5500 (Alpha Innotech). Relative densities were quantified (ImageJ, National Institutes of Health), and results are expressed in arbitrary units. Membranes were stained with Ponceau S (Sigma Chemical, St. Louis, MO) to ensure even loading.
Determination of metabolite concentrations. Muscle ATP, phosphocreatine, and lactate concentrations were measured on acidifiedneutralized extracts using fluorometric methods, as previously described (7, 11) .
Statistics. PDHa activity and muscle metabolites were analyzed with SigmaStat (Port Richmond, CA) as a two-way ANOVA [stimulation frequency (rest, 10 Hz, 40 Hz) and genotype]. Force data were examined within 40-or 10-Hz stimulation using a two-way ANOVA (time of stimulation and genotype). When significance was detected, means were compared using Tukey's post hoc test. For protein contents and total PDK activity data, an unpaired two-tailed t-test was used. Significance was accepted at P Յ 0.05.
RESULTS
Animal and muscle weights. WT and PDK2KO mice were similar phenotypically, and their body weights (21.0 Ϯ 0.5 and 23.0 Ϯ 0.3 g, respectively) and muscle (EDL) weights (12.4 Ϯ 0.5 and 13.0 Ϯ 0.4 mg, respectively) were not significantly different.
Force. At 10 Hz, there were no statistical differences between WT and PDK2KO muscle force, and force was maintained throughout the 3-min duration (Table 1) . However, at 40 Hz, force was ϳ12% lower in PDK2KO muscles (P Ͻ 0.001; Table 1 ). Although force did not significantly change with time during the 3 min at 40 Hz (P ϭ 0.07), when normalized to initial force, WT and PDK2KO muscles declined to ϳ75% of the initial force by 3 min (data not shown). There were no statistical differences in the force-frequency curves between PDK2KO and WT muscles (data not shown).
PDHa activity. There was a main effect for PDHa activity to increase with the intensity of muscle contraction for WT and PDK2KO muscles. There was also a main effect for lower PDHa activity during contraction in PDK2KO than WT muscles (Fig. 1) .
Total PDK activity. Total PDK activity was nearly fourfold greater in WT than PDK2KO mice (P Ͻ 0.05; Fig. 2A) .
PDK1, PDK2, and PDK4 content. PDK2 protein was not detected by Western blot analysis in mitochondria of PDK2KO mice, confirming ablation of the gene (Fig. 2B) . The PDK4 protein content was similar (P ϭ 0.19) in both genotypes (Fig.  2C) , while PDK1 protein content was almost twofold higher (P ϭ 0.008) in the PDK2KO mice (Fig. 2D) .
PDH complex subunits and COX IV content. Deletion of the PDK2 isoform increased the protein content of E1␣ ϳ32% (P ϭ 0.036; Fig. 3A ), but not E2 protein content (P ϭ 0.112; Fig. 3B ). This increase in E1␣ protein did not reflect a generalized change in mitochondrial oxidative capacity, since COX IV protein was not higher in PDK2KO mice (Fig. 3C) .
HIF-1␣ content. HIF-1␣ protein content was ϳ3.5-fold greater in the PDK2KO than WT mice (P ϭ 0.009; Fig. 4) .
Muscle metabolites. Muscle ATP concentrations were not different between genotypes at any stimulation frequency and were maintained at ϳ27-30 mmol/kg dry wt, indicating that viability was maintained during incubations (Table 2 ). Phosphocreatine was also maintained during resting contractions (confirming viability) and was not different between genotypes. However, there was a main effect for phosphocreatine to be lower after 40-Hz contractions than at rest (Table 2) . Similarly, muscle lactate was not different between the geno- Values are means Ϯ SE in N/g muscle wet wt. WT, incubated extensor digitorum longus from wild-type mice; PDK2KO, muscles from pyruvate dehydrogenase kinase isoform 2 (PDK2) knockout mice. *Main effect for lower force than WT. Fig. 1 . Activity of active pyruvate dehydrogenase (PDHa) at rest and during low-and moderate-intensity contraction in wild-type (WT) and PDH kinase (PDK) isoform 2 (PDK2) knockout (PDK2KO) mice. PDHa activity was measured on whole extensor digitorum longus (EDL) muscle homogenates. Values are means Ϯ SE (n ϭ 5 in each group). *Significant genotype main effect (P Ͻ 0.05). There was also a main effect regardless of genotype for stimulation treatment (P Ͻ 0.05).
types, and lactate increased to a similar extent in WT and PDK2KO muscles during the 40-Hz contractions (Table 2) .
DISCUSSION
This study describes the effects of deletion of PDK2 in mice on PDHa activity, the relative expressions of the remaining PDK isoforms, and their total combined activity in skeletal muscle during contraction. As well, muscle expression of the individual subunits of the PDH complex and the oxidative capacity of these genetically modified mice were examined. The major finding was that PDHa activity was lower during muscle contraction (but not at rest) in the PDK2KO than WT mice, despite the fact that these mice lack the most abundant PDK isoform and have markedly lower total PDK activity. There was significantly increased expression of PDK1 protein (but not PDK4), which correlated with an increased concentration of a transcription factor (HIF-1␣) that is normally associated with hypoxia. This adaptation to PDK2 ablation could account for the lower PDH activation during contraction in PDK2KO mice. In what appears to be an additional adaptive response, E1␣ protein expression was increased in PDK2KO mice, but this did not reflect a generalized increase in oxidative capacity.
PDHa and PDK activity. In sharp contrast to our hypothesis, PDK2 ablation did not increase PDHa activation at rest or during contraction but, instead, severely attenuated it. However, total PDK activity was considerably lower in PDK2KO than WT mice. Therefore, it is clear that PDHa activation during muscle contraction does not rely solely on total PDK activity but also relies on the collective kinetic properties of the population of PDK isoforms available to downregulate the complex. However, in resting muscle, PDHa activation appeared to be maintained in the PDK2KO mice, despite the markedly lower total PDK activity. A disconnect between total PDK activity and reciprocal PDHa activity has been previously observed (31, 41) , and others reported similar resting PDHa activity with different E1␣ phosphate content (21) . However, the fact that PDH activation appeared similar at rest could suggest that the changes in PDK1 expression were sufficient to maintain similar PDHa activity in resting muscle in the knockout mice, although it was more difficult to activate the complex when the muscles were contracting.
Despite the difficulty activating PDH activity during contractions, there were no differences in force development at 10 Hz, demonstrating that the reduced PDHa activity was sufficient to support ATP turnover rate at this intensity. However, at more intense 40-Hz contractions, initial force was ϳ12% lower in PDK2KO than WT muscles (although the relative fatigue profiles were similar). This would suggest that as ATP demand increased, force was modestly compromised likely due to decreased PDH activation. However, there was no significant difference in muscle phosphocreatine and lactate concentrations between the genotypes, indicating that, during the 3-min contractions, there was no compensation due to in- creased anaerobic ATP provision. This is an unexpected result, and it is possible that any increase in lactate production in the PDK2KO muscles was balanced by the rate of facilitated diffusion out of the muscle at this contraction intensity. It is also possible that if the contractions were more intense (40 Hz represented only ϳ60% of the maximal force in WT muscle), differences in substrate phosphorylation might have been observed.
PDK4, PDK1 and HIF-1␣. PDK1 protein content increased almost twofold in the PDK2KO mice, while PDK4 protein was unaltered. To our knowledge, this the first study to report an induction of PDK1 content in skeletal muscle. However, increased PDK1 was observed recently during hypoxic conditions through increased expression of the transcription factor HIF-1␣ in cultured mouse and human cells (37) . HIF-1␣ is Values are means Ϯ SE in mmol/kg dry wt. PCr, phosphocreatine. There was a main effect for stimulation condition for PCr and lactate. ATP concentrations were not different in any condition. responsible for regulating mitochondrial metabolism and is upregulated during hypoxia to increase the transcription of PDK1, thereby decreasing PDHa activity. This adaptation is thought to cause a reduction of NADH influx into the electron transport chain (ETC) during hypoxia and to reduce ETC activity in complexes I and III to compensate for the lack of oxygen provision for COX (37, 38) . We therefore checked for HIF-1␣ content in PDK2KO mice and discovered that expression was 3.5-fold higher in PDK2KO than WT mice, despite the fact that they were not hypoxic. It is possible that, by deleting the most abundant PDK isoform and by dropping total PDK activity so low, during PDK2KO development the muscle adapts to decrease the unregulated and unchecked influx of carbohydrate-derived reducing equivalents to the ETC through the transcription factor HIF-1␣, to ameliorate resting muscle PDHa activity. Although hypoxia is the most commonly studied regulator of HIF-1␣ expression, 2-oxoacids (e.g., pyruvate) (5) and reactive oxygen species (2, 38) have also been implicated in HIF-1␣ upregulation, indicating that HIF-1␣ plays a critical role in maintaining the balance between substrate supply to the ETC and redox homeostasis in protecting the organism (38) . Therefore, it would seem that induction of PDK1 by HIF-1␣ in the PDK2KO mice may be part of a mechanism to compensate for the negative effects on mitochondria caused by knocking out PDK2, potentially through increased reactive oxygen species production.
These results give some insight into the potency of PDK1 in terms of its ability to inhibit the PDH complex, because the increase in PDK1 protein content did not increase total PDK activity to WT levels; yet PDHa activity was lower during contraction. PDK1 is known to have a severe pyruvate insensitivity and is the only isoform that is able to phosphorylate site 3 of E1␣ (23) . PDHa activity of the complex can be sufficiently decreased only through the phosphorylation of site 1, while the phosphorylation of sites 2 and 3 effectively impedes activation of the complex by PDP (23, 36, 40) . This combined specific action and potency of PDK1 could be why it is targeted for upregulation in hypoxia and in PDK2KO mice to effectively shut down carbohydrate oxidation.
PDK2KO model. From these results, it is obvious that PDK2 is very important in the regulation of the PDH complex, and in its absence the compensation of PDK1 expression was necessary for proper complex regulation. In addition to compensating for the lack of PDK2 by increasing PDK1 expression, E1␣ protein content was higher in PDK2KO than WT muscle (although E2 content was not significantly different). Higher E1␣ may be due to the metabolic stress induced by the loss of PDK2 and the compensatory increase in PDK1, making it difficult to activate the PDH complex. This adaptation in E1␣ appears similar to previous literature in human skeletal muscle with 8 wk of endurance training (26) and 6 wk of sprint interval training (4), which, in general, increases the capacity for carbohydrate oxidation. Our work is consistent with this previous literature, which suggests that because E1␣ is ratelimiting for the decarboxylation of pyruvate to acetyl-CoA, it would adapt earlier to accommodate the need for increased oxidation, an idea that has been proposed for other tissues (28) . Specifically, for PDK2KO muscles, higher E1␣ protein seems to be a possible compensatory strategy to strive for improved PDHa activity by increasing the expression of this rate-limiting enzyme. This is likely important in these PDK2KO mice during exercise, since they appear to have increased difficulty activating or "turning on" the complex, even at a low-tomoderate contraction stimulus. However, this adaptation to increase PDH activity through the upregulation of PDH E1␣ does not reflect a generalized increase in oxidative capacity, as COX IV was unchanged in PDK2KO compared with WT mice.
This study has focused on changes on the "kinase" side of regulation of the PDH complex; therefore, it should be recognized that these PDK2KO mice may also have alterations in PDP activity and expression, and this should be the focus of future studies. However, in our experience, the changes in PDP activity and expression with starvation and obesity are far less robust than those observed in PDK regulation (24, 25) .
Perspectives and Significance
It appears that the individual regulatory properties of the PDK isoform population in the PDH complex have a significant influence on carbohydrate flux. This study removed the most abundant PDK isoform, thereby revealing the normal inhibitory role of the other two isoforms on the PDH complex. Essentially, under normal circumstances, PDK2 seems to play a role in "fine-tuning" the activation of the complex to effectively match carbohydrate oxidation to the energy demands because of its acute sensitivity to pyruvate inhibition and the cell's energy status. In this nonphysiological condition of PDK2 ablation, it is possible that, early in development, the resultant unchecked oxidation of carbohydrates triggered adaptations to compensate (HIF-1␣, PDK1, E1␣), which could be detrimental in situations requiring higher ATP turnover rates (e.g., exercise). Although time-course studies remain to be completed, these findings were likely increased during the life of the animal as an adaptation. Therefore, although inhibition of PDK2 has been considered a potential therapy for type 2 diabetes (29, 30) , care must be taken to examine the long-term effects of PDK2 inhibition in vivo.
This study was also the first physiological evidence that PDK1 is a very potent inhibitor of the PDH complex, which raises questions as to why it would be present in skeletal muscle at all. However, PDK1 is more abundant in heart muscle (3) and oxidative skeletal muscle (32) , both of which have an increased reliance on fat. Therefore, PDK1 may play a role in promoting potent inhibition of the PDH complex and, thereby, increasing fat oxidation in these tissues.
